Futibatinib is a treatment for cholangiocarcinoma. It zeroes in on FGFR2 fusions and acts as a picky inhibitor of something called fibroblast growth factor receptor, or FGFR. These tablets have the active stuff in them, like 4 mg each.
You’re supposed to take them once a day and get a total of 20 mg. The pills come in a pack with 28 doses in total. So, how it works is, Futibatinib stops those signaling pathways that FGFR2 fusions are using.
They come as 4 mg tablets. You need 20 mg a day, which is the routine. That adds up to 28 tablets in one bottle.
And by the way, knowing how well it works for treating cholangiocarcinoma and those FGFR2 gene changes gives us a better idea of how it’s used in medicine. This stuff is good because it’s selective, meaning it’s careful and keeps bad side effects down.
